cp wire

CP Wire Articles

FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer
  • Application based on data from PH III KEYNOTE-407 trial
  • PDUFA target date set for 10/30/2018


Merck (NYSE:MRK) announced on 7/02/2018 that the U.S. Food and Drug... read more

Mon, 07/2/18 - 09:16 am
Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) announced on 6/29/2018 detailed data from the ADVANCE Phase 3 study which showed that Rolontis had an absolute risk reduction of severe neutropenia... read more

Fri, 06/29/18 - 09:58 am
Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma



Kite, a Gilead Company (Nasdaq: GILD) announced on 6/29/2018 that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion... read more

Fri, 06/29/18 - 09:42 am
Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug

Argenx (Euronext & Nasdaq: ARGX) announced on 6/28/2018 the achievement of the second of two preclinical milestones towards... read more

Thu, 06/28/18 - 09:57 am
Arsanis Discontinues Ph II Trial of ASN100

Arsanis, Inc. (NASDAQ:ASNS) announced on 6/28/2018 the discontinuation of its Phase 2 clinical trial of ASN100 for the prevention of S. aureuspneumonia in high-risk, mechanically ventilated... read more

Thu, 06/28/18 - 09:43 am

Pages